Nalbuphine Hci Injection, Solution
Product Images NDC 51662-1420

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nalbuphine Hci (NDC 51662-1420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Labeling (Box Labeling)

This is a product description of a pharmaceutical compound known as EPVS Black s, contained in a multi-dose flip-top vial. Each milliliter (mL) of the solution comprises nalbuphine HC1, sodium citrate dihydrate, citric acid, anhydrous, methyparaben, and propyparaben with the addition of buffers, preservatives, and sodium chloride to adjust pH and osmolality. The recommended dose is not specified in the available text. The vial should be stored in a controlled room temperature range (20-25°C or 68-77°F) and protected from light until use. The text also includes instructions for handling and packaging the product.*

FDA Label Image

Boxed Warning (Boxed Warning)

This text is a warning about the potential life-threatening risks of using Nalbuphine Hydrochloride Injection with benzodiazepines or other central nervous system depressants. The combination can lead to respiratory depression, sedation, coma, and death. Dosages and durations of use should be kept to a minimum, and patients should be closely monitored for signs of these adverse effects. Physicians should only prescribe Nalbuphine Hydrochloride Injection together with benzodiazepines or other CNS depressants as a last resort when alternative treatment options are inadequate.*

FDA Label Image

How Supplied (How Supplied)

This is a description of the various packaging sizes and concentrations of a medication, which is available in ampuls and vials. The medication comes in concentrations of 10mg/mL, 20mg/mL, 100mg/10mL and 200mg/10mL, and is packaged in single-dose ampuls or multiple-dose fliptop vials. The NDC (National Drug Code) numbers provided indicate the codes used to identify the medication in the USA.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Labeling (Serialized Labeling)

FDA Label Image

Structure (Structure)

FDA Label Image

Vial Labeling (Vial Labeling)

This is a description for a medication called Nalbuphine HCI injection. It is a multiple-dose solution with a strength of 10mg/ml. The solution contains nalbuphine HCI, sodium citrate, citric acid, methylparaben, and propylparaben as preservatives. It can be used for IV, IM, or SC injections and should be stored at 20 to 25°C (68 to 77°F). The usual dosage can be found in the insert. This medication is sterile and should be protected from light.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.